{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:12:44Z","timestamp":1762305164233,"version":"build-2065373602"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2020\\u201306305"],"award-info":[{"award-number":["RGPIN-2020\\u201306305"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT34673"],"award-info":[{"award-number":["IT34673"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.toxlet.2025.04.013","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T20:30:49Z","timestamp":1745958649000},"page":"50-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The induction of quinone oxidoreductases NQO1 and NQO2 by clozapine: Potential implications for clozapine-induced agranulocytosis"],"prefix":"10.1016","volume":"409","author":[{"given":"Md Harunur","family":"Rashid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newton H.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"El-Ghiaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Chue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arno G.","family":"Siraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2025.04.013_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23243","article-title":"Mercury and methylmercury differentially modulate hepatic cytochrome P450 1A1 and 1A2 in vivo and in vitro","volume":"37","author":"Alqahtani","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxlet.2025.04.013_bib3","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/14740338.2017.1376645","article-title":"Non-chemotherapy drug-induced neutropenia - an update","volume":"16","author":"Andr\u00e8s","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.toxlet.2025.04.013_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/abbi.2001.2642","article-title":"The neutrophil NADPH oxidase","volume":"397","author":"Babior","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.toxlet.2025.04.013_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/DTI.S1146","article-title":"A model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) targeted individualized cancer chemotherapy","volume":"4","author":"Begleiter","year":"2009","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.toxlet.2025.04.013_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0006-2952(01)00537-8","article-title":"Factors influencing the induction of DT-diaphorase activity by 1,2-dithiole-3-thione in human tumor cell lines","volume":"61","author":"Begleiterabc","year":"2001","journal-title":"Biochem. Pharm."},{"issue":"14","key":"10.1016\/j.toxlet.2025.04.013_bib7","first-page":"2839","article-title":"Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone","volume":"57","author":"Rothman","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2025.04.013_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JCP.0000000000000478","article-title":"Clozapine Underutilization in the treatment of schizophrenia: how can clozapine prescription rates be improved?","volume":"36","author":"Bogers","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/acs.chemrestox.7b00289","article-title":"Reduction and scavenging of chemically reactive drug metabolites by NAD(P)H:quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 and variability in hepatic concentrations","volume":"31","author":"Braver-Sewradj","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1155\/2009\/503916","article-title":"Clozapine-induced fatal fulminant hepatic failure: a case report","volume":"23","author":"Chang","year":"2009","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib11","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.amepre.2017.07.019","article-title":"Prevalence and medical costs of chronic diseases among adult medicaid beneficiaries","volume":"53","author":"Chapel","year":"2017","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.toxlet.2025.04.013_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/acs.chemrestox.6b00357","article-title":"How reactive metabolites induce an immune response that sometimes leads to an idiosyncratic drug reaction","volume":"30","author":"Cho","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pnpbp.2006.07.003","article-title":"Leukopenia and neutropenia induced by quetiapine","volume":"31","author":"Cowan","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.toxlet.2025.04.013_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1176\/appi.psy.42.4.368","article-title":"Acute neutropenia in a patient treated with quetiapine","volume":"42","author":"Croarkin","year":"2001","journal-title":"Psychosomatics"},{"key":"10.1016\/j.toxlet.2025.04.013_bib15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/ars.2020.8030","article-title":"The role of myeloperoxidase in biomolecule modification, chronic inflammation, and disease","volume":"32","author":"Davies","year":"2020","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.toxlet.2025.04.013_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-2000-8359","article-title":"Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6","volume":"33","author":"Dettling","year":"2000","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.toxlet.2025.04.013_bib17","doi-asserted-by":"crossref","unstructured":"L. Ernster, DT Diaphorase, in: 1967: pp. 309\u2013317. https:\/\/doi.org\/10.1016\/0076-6879(67)10059-1.","DOI":"10.1016\/0076-6879(67)10059-1"},{"key":"10.1016\/j.toxlet.2025.04.013_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.jcp.0000177668.42640.fe","article-title":"Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients","volume":"25","author":"Fehsel","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1472-8206.1997.tb00195.x","article-title":"Metabolism of clozapine by human neutrophils: evidence for a specific oxidation of clozapine by the myeloperoxidase system with inhibition of enzymatic chlorination cycle","volume":"11","author":"Frimat","year":"1997","journal-title":"Fundam. Clin. Pharm."},{"key":"10.1016\/j.toxlet.2025.04.013_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S0026-895X(24)13269-5","article-title":"A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo","volume":"53","author":"Gardner","year":"1998","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.toxlet.2025.04.013_bib21","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/tx050095o","article-title":"A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo","volume":"18","author":"Gardner","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2016.08.021","article-title":"NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic \u03b2-cells","volume":"262","author":"Gray","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2025.04.013_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0300-483X(93)90066-2","article-title":"Myeloperoxidase-mediated activation of xenobiotics by human leukocytes","volume":"82","author":"Hofstra","year":"1993","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2025.04.013_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/JCP.0000000000000904","article-title":"Analysis of clozapine use and safety by using comprehensive national data from the Japanese Clozapine patient monitoring service","volume":"38","author":"Inada","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"41","key":"10.1016\/j.toxlet.2025.04.013_bib25","doi-asserted-by":"crossref","first-page":"30917","DOI":"10.1074\/jbc.M605809200","article-title":"NQO1 and NQO2 regulation of humoral immunity and autoimmunity*","volume":"281","author":"Iskander","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2025.04.013_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0009-2797(02)00061-3","article-title":"Predicting drug-induced agranulocytosis: Characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis","volume":"142","author":"Iverson","year":"2002","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.toxlet.2025.04.013_bib27","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2025.04.013_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40273-016-0444-6","article-title":"The societal cost of schizophrenia: a systematic review","volume":"35","author":"Jin","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.toxlet.2025.04.013_bib29","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2025.04.013_bib30","series-title":"Casarett and Doull\u2019s Toxicology: The Basic Science of Poisons,","first-page":"188","author":"Klaassen","year":"2008"},{"key":"10.1016\/j.toxlet.2025.04.013_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/pgs-2018-0188","article-title":"Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective","volume":"20","author":"Legge","year":"2019","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.toxlet.2025.04.013_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JCP.0000000000001606","article-title":"The Modernization of Clozapine: a recapitulation of the past in the united states and the view forward","volume":"42","author":"Leung","year":"2022","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/phar.2887","article-title":"A systematic review of clozapine-associated inflammation and related monitoring","volume":"43","author":"Leung","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.toxlet.2025.04.013_bib34","doi-asserted-by":"crossref","unstructured":"S. Levy, H.J. Forman, c-Myc is a Nrf2-interacting protein that negatively regulates phase II genes through their electrophile responsive elements, (n.d.). https:\/\/doi.org\/10.1002\/iub.314.","DOI":"10.1002\/iub.314"},{"key":"10.1016\/j.toxlet.2025.04.013_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0076-6879(90)86122-C","article-title":"DT-diaphorase: purification, properties, and function","volume":"186","author":"Lind","year":"1990","journal-title":"Methods Enzym."},{"key":"10.1016\/j.toxlet.2025.04.013_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)12207-6","article-title":"Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells","volume":"275","author":"Liu","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2025.04.013_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/tx500019u","article-title":"Involvement of myeloperoxidase and NADPH oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: implications for drug-induced agranulocytosis","volume":"27","author":"Lobach","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib38","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/cbdv.200900055","article-title":"Structural alerts, reactive metabolites, and protein covalent binding: how reliable are these attributes as predictors of drug toxicity?","volume":"6","author":"M.T.D. A. S. Kalgutkar","year":"2009","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.toxlet.2025.04.013_bib39","doi-asserted-by":"crossref","unstructured":"Z.H. Maayah, T. Zhang, M.Laird Forrest, S. Alrushaid, M.R. Doschak, N.M. Davies, A.O.S. El-Kadi, pharmaceutics DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways, (n.d.). https:\/\/doi.org\/10.3390\/pharmaceutics10030144.","DOI":"10.3390\/pharmaceutics10030144"},{"key":"10.1016\/j.toxlet.2025.04.013_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)12206-4","article-title":"The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man","volume":"275","author":"Maggs","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2025.04.013_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.euroneuro.2023.04.003","article-title":"Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: a meta-analysis","volume":"73","author":"Martins","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0009-2797(90)90009-C","article-title":"Myeloperoxidase catalysed cooxidative metabolism of methimazole: oxidation of glutathione and NADH by free radical intermediates","volume":"73","author":"McGirr","year":"1990","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.toxlet.2025.04.013_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","article-title":"Clozapine: balancing safety with superior antipsychotic efficacy","volume":"6","author":"Meltzer","year":"2012","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.toxlet.2025.04.013_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000204146","article-title":"Agranulocytosis due to the occurrence of leukocyte-agglutinins; pyramidon and cold agglutinins","volume":"8","author":"Moeschlin","year":"1952","journal-title":"Acta Haematol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/01.jcp.0000144891.52858.a6","article-title":"Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis","volume":"24","author":"Mosyagin","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib46","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1021\/tx980148k","article-title":"Metabolism-dependent neutrophil cytotoxicity of amodiaquine: a comparison with pyronaridine and related antimalarial drugs","volume":"11","author":"Naisbitt","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib47","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/tx500183x","article-title":"Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis","volume":"27","author":"Ng","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01049","article-title":"Clozapine pharmacogenetic studies in schizophrenia: efficacy and agranulocytosis","volume":"9","author":"Numata","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.toxlet.2025.04.013_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1399-0039.2003.00133.x","article-title":"NQO2 gene is associated with clozapine-induced agranulocytosis","volume":"62","author":"Ostrousky","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.toxlet.2025.04.013_bib50","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/0006-2952(87)90519-3","article-title":"Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity","volume":"36","author":"Powis","year":"1987","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.toxlet.2025.04.013_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109574","article-title":"Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants","volume":"345","author":"Rashid","year":"2021","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.toxlet.2025.04.013_bib52","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/acs.chemrestox.2c00008","article-title":"Neutrophil myeloperoxidase-mediated N-demethylation of quetiapine leads to N-desalkylquetiapine, a pharmacologically active cytochrome P450 metabolite","volume":"35","author":"Rashid","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101950","article-title":"The diverse functionality of NQO1 and its roles in redox control","volume":"41","author":"Ross","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/tx00001a013","article-title":"Metabolism of procainamide to a hydroxylamine by human neutrophils and mononuclear leukocytes","volume":"1","author":"Rubin","year":"1988","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.2001.00429.x","article-title":"Agranulocytosis and granulocytopenia associated with quetiapine","volume":"104","author":"Ruh\u00e9","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.toxlet.2025.04.013_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1124\/pharmrev.120.000090","article-title":"The emerging role of the innate immune response in idiosyncratic drug reactions","volume":"73","author":"Sernoskie","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxlet.2025.04.013_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021243","article-title":"The role of myeloperoxidase in clozapine-induced inflammation: a mechanistic update for idiosyncratic drug-induced Agranulocytosis","volume":"24","author":"Sernoskie","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2025.04.013_bib58","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1176\/appi.psy.48.6.530","article-title":"Quetiapine-induced leucopenia and thrombocytopenia","volume":"48","author":"Shankar","year":"2007","journal-title":"Psychosomatics"},{"key":"10.1016\/j.toxlet.2025.04.013_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00008571-199902000-00015","article-title":"Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1","volume":"9","author":"Siegel","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.toxlet.2025.04.013_bib60","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/tx200168d","article-title":"Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States","volume":"24","author":"Stepan","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib61","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.toxlet.2025.04.013_bib62","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0006-2952(95)00236-S","article-title":"The bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro: chemical mechanisms and the effects of fluorine substitution","volume":"50","author":"Tingle","year":"1995","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.toxlet.2025.04.013_bib63","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0006-2952(03)00013-3","article-title":"Cytotoxicity and apoptosis of benzoquinones: redox cycling, cytochrome c release, and BAD protein expression","volume":"65","author":"Tudor","year":"2003","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.toxlet.2025.04.013_bib64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/03602539208996297","article-title":"The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions","volume":"24","author":"Uetrecht","year":"1992","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxlet.2025.04.013_bib65","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1021\/acs.chemrestox.2c00090","article-title":"Idiosyncratic drug reactions: a 35-year chemical research in toxicology perspective","volume":"35","author":"Uetrecht","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/tx00044a007","article-title":"Oxidation of aminopyrine by hypochlorite to a reactive dication: possible implications for aminopyrine-induced agranulocytosis","volume":"8","author":"Uetrecht","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)22554-X","article-title":"Metabolism of vesnarinone by activated neutrophils: implications for vesnarinone-induced agranulocytosis","volume":"270","author":"Uetrecht","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2025.04.013_bib68","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/tx00020a015","article-title":"N-Chlorination and oxidation of procainamide by myeloperoxidase: toxicological implications","volume":"4","author":"Uetrecht","year":"1991","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0009-2797(97)00017-3","article-title":"Structural features associated with reactive metabolite formation in clozapine analogues","volume":"104","author":"Uetrecht","year":"1997","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.toxlet.2025.04.013_bib70","first-page":"471","article-title":"Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population","volume":"17","author":"Van Der Weide","year":"2017","journal-title":"Pharm. J."},{"key":"10.1016\/j.toxlet.2025.04.013_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-016-0056-z","article-title":"Activation of NQO1 in NQO1*2 polymorphic human leukemic HL-60 cells by diet-derived sulforaphane","volume":"5","author":"Wu","year":"2015","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.toxlet.2025.04.013_bib72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/bmj.2.4621.261","article-title":"Leucocyte counts in the prevention of drug agranulocytosis","volume":"2","author":"Young","year":"1949","journal-title":"Br. Med. J."},{"key":"10.1016\/j.toxlet.2025.04.013_bib73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0748233709102209","article-title":"Signaling pathways involved in phase II gene induction by \u03b1, \u03b2-unsaturated aldehydes","volume":"25","author":"Zhang","year":"2009","journal-title":"Toxicol. Ind. Health"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427425000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427425000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:10:01Z","timestamp":1762305001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427425000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":73,"alternative-id":["S0378427425000797"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2025.04.013","relation":{},"ISSN":["0378-4274"],"issn-type":[{"type":"print","value":"0378-4274"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The induction of quinone oxidoreductases NQO1 and NQO2 by clozapine: Potential implications for clozapine-induced agranulocytosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2025.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}